RT Journal
A1 DeMonaco HJ
T1 Patient- and physician-oriented web sites and drug surveillance: Bisphosphonates and severe bone, joint, and muscle pain
JF Archives of Internal Medicine
JO Archives of Internal Medicine
YR 2009
FD June 22
VO 169
IS 12
SP 1164
OP 1166
DO 10.1001/archinternmed.2009.133
UL http://dx.doi.org/10.1001/archinternmed.2009.133
AB 
Postmarketing surveillance and the determination of the real-world safety profile of prescription drugs is arguably flawed. Recent identification of significant adverse effects associated with newly approved prescription drugs support the sometimes-held view that a new system needs to be introduced. The present voluntary system has not provided a sufficient early warning system, and some have called for active systems that probe for potential adverse effects of approved prescription drugs.1 Patient-oriented Web sites may provide an opportunity to identify potential adverse effects early in a drug's postmarket history.